Science

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang/LinkedIn

Mar 4, 2025, 05:27

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

Lili Yang, Professor of Microbiology, Immunology and Molecular Genetics at University of California, Los Angeles (UCLA), shared her recent article on LinkedIn:

“January 17, 2025- Our protocol article is published on Nature Protocols, reporting generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture.

Congratulations to all the authors, in particular the co-first authors Yan-Ruide (Charlie) Li, Kuangyi (Coin) Zhou, and Derek Lee!”

Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture

Authors: Yan-Ruide Li, et al.

Lili Yang: Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy

allogeneic cancer CAR-NKT cells Derek Lee fight against cancer Global fight against cancer immunology immunotherapy Kuangyi (Coin) Zhou Lili Yang Microbiology Molecular Genetics Nature Protocols OncoDaily Oncology UCLA University of California Yan-Ruide (Charlie) Li

Beyond the Red Carpet: Oscar Winners and Nominees Who Fought Cancer

Oncologist Near Me – Lidia Schapira: A Leader in Cancer Care and Medical Education

CancerWorld welcomes their Co-Editors-in-Chief

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma